Financials data is unavailable for this security.
View more
Year on year Tong Ren Tang Technologies Co Ltd had little change in net income (from 582.89m to 590.19m) despite revenues that grew 13.04% from 5.99bn to 6.77bn. A factor has been an increase in the selling, general and administrative costs as a percentage of sales from 22.63% to 25.12%.
| Gross margin | 40.97% |
|---|---|
| Net profit margin | 14.76% |
| Operating margin | 16.78% |
| Return on assets | 7.42% |
|---|---|
| Return on equity | 9.44% |
| Return on investment | 11.69% |
More ▼
Cash flow in CNYView more
In 2023, cash reserves at Tong Ren Tang Technologies Co Ltd fell by 975.21m. However, the company earned 554.18m from its operations for a Cash Flow Margin of 8.18%. In addition the company used 1.07bn on investing activities and also paid 497.76m in financing cash flows.
| Cash flow per share | 1.11 |
|---|---|
| Price/Cash flow per share | 5.01 |
| Book value per share | 6.03 |
|---|---|
| Tangible book value per share | 5.98 |
More ▼
Balance sheet in CNYView more
| Current ratio | 4.34 |
|---|---|
| Quick ratio | 2.30 |
| Total debt/total equity | 0.3401 |
|---|---|
| Total debt/total capital | 0.1968 |
More ▼
Growth rates in CNY
Year on year, both dividends per share and earnings per share excluding extraordinary items growth increased 15.80% and 1.25%, respectively. The positive trend in dividend payments is noteworthy since very few companies in the Major Drugs industry pay a dividend. Additionally when measured on a five year annualized basis, both dividend per share and earnings per share growth ranked in-line with the industry average relative to its peers.
| Div yield(5 year avg) | 2.81% |
|---|---|
| Div growth rate (5 year) | -0.01% |
| Payout ratio (TTM) | 31.49% |
| EPS growth(5 years) | -2.73 |
|---|---|
| EPS (TTM) vs TTM 1 year ago | 2.86 |
More ▼
